Niki BioSolutions, Inc. (NIKI) — Financial Flexibility Index
Niki BioSolutions, Inc. (NIKI) has a Financial Flexibility Index of -0.11x as of December 2025. Free cash flow of $-535.25K (operating CF $-535.25K minus capex $5.00) represents 0% of total liabilities ($4.90 Million). For the full cash flow conversion analysis, see Niki BioSolutions, Inc. cash flow conversion.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Niki BioSolutions, Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Niki BioSolutions, Inc. across 9 annual periods. Check Niki BioSolutions, Inc. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Financial Flexibility Index for Niki BioSolutions, Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Niki BioSolutions, Inc.. Check Niki BioSolutions, Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.37x | $-1.84 Million | $-1.84 Million | $4.90 Million | ▼ -37.1% |
| 2024 | -0.27x | $-1.19 Million | $-1.19 Million | $4.35 Million | ▲ +81.4% |
| 2023 | -1.47x | $-7.72 Million | $-7.72 Million | $5.26 Million | ▼ -57.8% |
| 2022 | -0.93x | $-12.13 Million | $-12.32 Million | $13.03 Million | ▲ +71.8% |
| 2021 | -3.30x | $-14.51 Million | $-14.65 Million | $4.40 Million | ▼ -27.1% |
| 2020 | -2.59x | $-15.77 Million | $-15.93 Million | $6.08 Million | ▼ -92.4% |
| 2019 | -1.35x | $-12.28 Million | $-13.38 Million | $9.10 Million | ▼ -318.7% |
| 2018 | -0.32x | $-3.97 Million | $-10.04 Million | $12.33 Million | ▲ +84.3% |
| 2017 | -2.05x | $-2.72 Million | $-5.78 Million | $1.33 Million | — |